Participants:0–17 years · 18–64 years · 65+ years
Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone

Contact Research Centre

Primary progressive multiple sclerosis

Recruiting

Investigational

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational

France

Participants:18–64 years

Contact Research Centre

Psoriatic arthropathy

Recruiting

Investigational

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Dermatitis atopic+1

Recruiting

Investigational

Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

Investigational

France

Participants:0–17 years
Substances:Lebrikizumab

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

Investigational

France

Participants:18–64 years · 65+ years

Contact Research Centre

Bladder transitional cell carcinoma+1

Recruiting

Registered drug

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Enfortumab Vedotin

Contact Research Centre

Cardiac failure+1

Recruiting

Investigational

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational

France

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 2

4 188 trials match your criteria

Chronic obstructive pulmonary disease

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Narcolepsy

Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

Narcolepsy

Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

Systemic lupus erythematosus

Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

Asthma

Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

Renal disorder

BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Primary progressive multiple sclerosis

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Psoriatic arthropathy

Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

Dermatitis atopic+1

Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

Amyotrophic lateral sclerosis

A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

Bladder transitional cell carcinoma+1

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Cardiac failure+1

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.